CHMFL-ABL-039

• Description :

  CHMFL-ABL-039 is a type II native ABL kinase and drug-resistant V299L mutant BCR-ABL inhibitor (IC50s: 7.9 nM and 27.9 nM) used in the research of chronic myeloid leukemia.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  594.639

• Molecular Formula :

  C31H33F3N6O3

• Notes :

  Research use only, not for human use.

• Receptor :

  Apoptosis| DUSP6

• CAS Number :

  2304344-56-5